Pregnancy hypertension · 2026
Childhood neurodevelopmental outcomes following hypertensive disorders of pregnancy.
Clinical StudyСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Martin Samantha L, Grantz Katherine L, Grobman William, Sciscione Anthony, Skupski Daniel, Palomares Kristy, Wapner Ronald, Vena John E, Newman Roger B, Hunt Kelly, Tita Alan, ECHO National Fetal Growth Study Consortium
Аннотация
OBJECTIVE: To compare neurodevelopmental (ND) outcomes in children of mothers who experienced hypertensive disorders of pregnancy (HDP) compared to normotensive mothers using data from a prospective cohort study.
STUDY DESIGN: Secondary analysis of ND outcomes in children (aged 4-8 years) born to women who received serial fetal growth ultrasounds in the National Fetal Growth Study. The primary and secondary outcomes were executive and motor functioning scores, respectively (NIH toolbox measures and parent reported scales from Ages and Stages Questionnaire, Behavior, and Autism Scores). The primary exposure was HDP, defined as preeclampsia (PE) or gestational hypertension (GHTN), compared to normotensive. Additionally, PE and GHTN subgroups were compared to normotensive. Linear regression models with significant covariates yielded adjusted mean differences (95% CI).
RESULTS: Of 675 children, 63 (9.3%) had HDP, of whom 28 (4.1%) had PE and 35 (5.2%) had GHTN. Those with HDP had lower gestational age at delivery (38.4 vs. 39.5 wks.), higher pre-pregnancy BMI (26.4 vs. 24.2 kg/m2), and higher prevalence of nulliparity (62.0% vs. 44.0%; all p < 0.01). After adjustments, mean scores for all ND outcomes were lower for those with in-utero exposure to HDP compared to normotensive women, but the only significant difference was in executive functioning for children between 3 and 7 years old (mean difference = -3.02, 95% CI -5.70, -0.33).
CONCLUSION: In-utero exposure to HDP is associated with increased risks for poor executive functioning, with PE potentially having a stronger association with these long-term ND outcomes than GHTN.
CLINICALTRIALS: gov Identifiers: NCT00912132.
STUDY DESIGN: Secondary analysis of ND outcomes in children (aged 4-8 years) born to women who received serial fetal growth ultrasounds in the National Fetal Growth Study. The primary and secondary outcomes were executive and motor functioning scores, respectively (NIH toolbox measures and parent reported scales from Ages and Stages Questionnaire, Behavior, and Autism Scores). The primary exposure was HDP, defined as preeclampsia (PE) or gestational hypertension (GHTN), compared to normotensive. Additionally, PE and GHTN subgroups were compared to normotensive. Linear regression models with significant covariates yielded adjusted mean differences (95% CI).
RESULTS: Of 675 children, 63 (9.3%) had HDP, of whom 28 (4.1%) had PE and 35 (5.2%) had GHTN. Those with HDP had lower gestational age at delivery (38.4 vs. 39.5 wks.), higher pre-pregnancy BMI (26.4 vs. 24.2 kg/m2), and higher prevalence of nulliparity (62.0% vs. 44.0%; all p < 0.01). After adjustments, mean scores for all ND outcomes were lower for those with in-utero exposure to HDP compared to normotensive women, but the only significant difference was in executive functioning for children between 3 and 7 years old (mean difference = -3.02, 95% CI -5.70, -0.33).
CONCLUSION: In-utero exposure to HDP is associated with increased risks for poor executive functioning, with PE potentially having a stronger association with these long-term ND outcomes than GHTN.
CLINICALTRIALS: gov Identifiers: NCT00912132.